Publications by authors named "Galyna Afonina"

The immune response in heparin-induced thrombocytopenia is initiated by and directed to large multimolecular complexes of platelet factor 4 (PF4) and heparin (H). We have previously shown that PF4:H multimolecular complexes assemble through electrostatic interactions and, once formed, are highly immunogenic in vivo. Based on these observations, we hypothesized that other positively charged proteins would exhibit similar biologic interactions with H.

View Article and Find Full Text PDF
Article Synopsis
  • Haemophilus ducreyi causes chancroid and relies on humans for heme, with a vaccine using the hemoglobin receptor HgbA showing effectiveness against a specific strain.
  • The study tested a new vaccine formulation (nHgbAI/MPL) and found it protected pigs from a homologous strain but not from a different strain, indicating a limit to its efficacy.
  • Despite lower antibody levels compared to the previous vaccine, the nHgbAI/MPL vaccine could block binding to the target, implying a need for a broader vaccine approach.
View Article and Find Full Text PDF

HgbA is the sole TonB-dependent receptor for hemoglobin (Hb) acquisition of Haemophilus ducreyi. Binding of Hb to HgbA is the initial step in heme acquisition from Hb. To better understand this step, we mutagenized hgbA by deletion of each of the 11 putative surface-exposed loops and expressed each of the mutant proteins in trans in host strain H.

View Article and Find Full Text PDF

The etiologic agent of chancroid is Haemophilus ducreyi. To fulfill its obligate requirement for heme, H. ducreyi uses two TonB-dependent receptors: the hemoglobin receptor (HgbA) and a receptor for free heme (TdhA).

View Article and Find Full Text PDF

Previously, we showed that serum resistance in Haemophilus ducreyi type strain 35000HP required expression of the outer membrane protein DsrA because the isogenic dsrA mutant FX517 is highly serum susceptible. In this study, we confirmed this finding by construction of additional serum-susceptible dsrA mutants in more recently isolated serum-resistant strains. We also demonstrated that killing of dsrA mutants required an intact classical complement cascade but not the alternative or mannan-binding lectin pathways.

View Article and Find Full Text PDF